We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Potiga

News List

GSK's anti-seizure drug shows promise in early depression study pharmafile
November 20, 2018
Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications as a treatmen
Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications as a treatment for treatment-resistant depression pharmafile
November 06, 2018
Following its approval in the US, the FDA ordered GSK to conduct additional safety studies after concerns were raised that the drug’s use could affect...
GSK's anti-seizure drug shows promise in early depression study pharmafile
November 05, 2018
Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have ....